GHP Funds

SVP I

SVP I, the debut fund for the firm, closed in December 2002 and invested with four highly successful leveraged buyout funds. SVP I is diversified by sector and geography.

Learn More
SVP II

SVP II is a leveraged buyout fund of funds which closed in December 2006. SVP II represents a continuation of the successful strategy utilized by the predecessor fund, primarily investing with large, top tier LBO and growth equity firms. SVP II is diversified by sector and geography.

Learn More
SVP RE I

SVP Real Estate I, LP ("SVP RE I"), closed in February 2008, is a private real estate fund of funds. As with SVP I & II, SVP RE I received allocations with historically successful, highly sought after underlying fund managers who pursue compelling investment strategies. The fund is diversified by sector (Office, Hotel, Industrial/Warehouse, Retail and Residential) and geography (U.S., Europe, and Asia/Pacific).

Learn More
GHP COF

The GHP Credit Opportunity Fund (“GHP COF”) is a fund of alternative credit and distressed debt funds that is being raised and invested to pursue two specific investment themes: (1) the de-leveraging of European Banks, and (2) the potential for a distressed cycle in U.S. High Yield Credit. GHP COF will pursue complex liquid and illiquid credit opportunities in the U.S. and Europe.

Learn More

GHP Library

Shoppers to Boost Medical Cannabis Patient Acquisition with HelloMD Partnership

Posted on by Granite Hall Partners
HelloMD chosen as first telehealth provider for Medical Cannabis by Shoppers website

TORONTO, May 1, 2019 /CNW/ – HelloMD will now provide patients in Canada with convenient access to practitioner-led advice about medical cannabis through a new relationship with Shoppers Drug Mart’s online medical cannabis platform.

Since its launch in 2015, HelloMD’s turnkey telehealth platform has facilitated more than 100,000 virtual consults between medical cannabis patients and licensed practitioners. HelloMD is currently active in Canada and the United States.

The Medical Cannabis by Shoppers website now features a dedicated portal operated by HelloMD. Patients can access live video consultations with licensed healthcare practitioners through the dedicated portal seven days a week, from the comfort of their home.

Following a consultation with a healthcare practitioner, patients that receive a medical document authorizing their registration as a medical cannabis patient may return to the Medical Cannabis by Shoppers website to register and begin choosing from its wide selection of approved products, or direct HelloMD to send their medical document to an alternative licensed producer.

We are honoured that Shoppers Drug Mart has trusted us to provide discreet, expert guidance to their patients seeking online advice about medical cannabis. We are excited to be part of this innovation, and to help Canadian patients get more convenient access to information and treatment.

Larry Lisser, senior vice-president of business development at HelloMD
About HelloMD

HelloMD is the leading digital health care platform for medical cannabis, and has facilitated more than 100,000 virtual consults between cannabis patients and licensed practitioners. The company’s white-label solutions enable third parties to quickly deploy a turnkey telehealth solution, complete with the technology, practitioners and support personnel required to improve patient onboarding processes.

Original press release

Leave a Comment